Cellular Engineering Technologies (CET) combines engineering with life science for preclinical drug discovery. It specializes in stem cells obtained from human non-embryonic sources. CET has as well the expertise in synthetic molecular biology, cloning and production of cells. The company, with over 70 years of collective cellular and tissue engineering experience, offers a range of research services to its clients. It also provides contractual research services by assisting in recruiting patients to harvest target cells for creating patient and disease-specific cell lines. CET is Iowa's premier non-embryonic stem cell company and made a stem cell alliance with Thermo Fisher Scientific.

Venture Information
Stage: 
In formation
Industry: 
Therapeutics & Drugs
Type of Product: 
tissue engineering
Market: 
A biotechnology tissue engineering company.
Company Information
Founders: 
Alan Moy